Clinical outcomes after TAVR with heparin or bivalirudin as periprocedural anticoagulation in patients with and without peripheral arterial disease: Results from the BRAVO‐3 randomized trial

OBJECTIVES: This study sought to investigate the clinical outcomes of patients with and without peripheral artery disease (PAD) in the BRAVO‐3 trial with respect to the effect of bivalirudin versus unfractionated heparin (UFH). BACKGROUND: PAD is found frequently in patients undergoing transcatheter...

Descripción completa

Detalles Bibliográficos
Autores principales: Zilberszac, Robert, Chandiramani, Rishi, Hengstenberg, Christian, Sartori, Samantha, Cao, Davide, Chandrasekhar, Jaya, Schafer, Ulrich, Tchetche, Didier, Violini, Roberto, Jeger, Raban, Van Belle, Eric, Boekstegers, Peter, Hambrecht, Rainer, Tron, Christophe, Dumenteil, Nicolas, Linke, Axel, ten Berg, Jurriën M., Deliargyris, Efthymios N., Anthopoulos, Prodromos, Mehran, Roxana, Dangas, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
VALVULAR AND STRUCTURAL HEART DISEASES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7540270/
https://www.ncbi.nlm.nih.gov/pubmed/31808295
http://dx.doi.org/10.1002/ccd.28642

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7540270/
https://www.ncbi.nlm.nih.gov/pubmed/31808295
http://dx.doi.org/10.1002/ccd.28642

Ejemplares similares